Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis.
Susumu YamazakiMasaki ShimizuYuko AkutsuAsami ShimboMasaaki MoriPublished in: Modern rheumatology (2022)
Tacrolimus is an effective and safe therapeutic alternative for approximately 60% of patients with JIA.